🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Autoimmune Hepatitis

Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors NCT06470997n/a1 site📍 Montpellier University Hospital, Montpellier · Tests: Blood sample collection, Liver biopsy Belimumab in Autoimmune Hepatitis NCT06381453Phase 26 sites📍 Calgary📍 Vancouver📍 Hamilton University Health Network, Toronto · Tests: Belimumab Auto-Injector [Benlysta] Swiss Autoimmune Hepatitis Cohort Study NCT03146884n/a20 sites📍 Lugano📍 Basel📍 Basel Fondazione Epatocentro Ticino Autoimmune Hepatitis Cohort in China NCT05785793n/a1 site📍 Shanghai Shanghai Jiao Tong University School of Medicine Host-Diet-Gut Interaction Post Vegan Diet in Pediatric Autoimmune Hepatitis. NCT07118657NA1 site📍 New Delhi Institute of Liver and Biliary Sciences, India · Tests: Vegan Diet, Standard Diet Canadian Network for Autoimmune Liver Disease NCT03569826n/a15 sites📍 Calgary📍 Edmonton📍 Vancouver University Health Network, Toronto · Tests: Observational; no intervention MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease NCT03178630n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati PredIcting sterOid depeNdEnt livEr injuRy With Polyreactive Immunoglobulin G NCT05810480n/a6 sites📍 Aachen📍 Hamburg📍 Hanover Hannover Medical School · Tests: polyreactive immunoglobulin G MRI Based Biomarkers in Pediatric Autoimmune Liver Disease NCT03175471n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing NCT01280825n/a1 site📍 Chicago University of Chicago A Study of SIPLIZUMAB in AILD and LT Patients NCT06455280Phase 11 site📍 New York Elizabeth C. Verna · Tests: Siplizumab Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients NCT06250309NA1 site📍 Indianapolis Indiana University · Tests: Dietary assignment Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage NCT06078098n/a1 site📍 Monza University of Milano Bicocca · Tests: Clinical Information A Trial of Inebilizumab in Participants With Autoimmune Hepatitis NCT07598825Phase 320 sites📍 Little Rock📍 Rialto📍 Valencia Amgen · Tests: Inebilizumab, Placebo, Standard of Care An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis NCT05335603n/a1 site📍 Hvidovre University of Copenhagen Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome NCT06519162n/a1 site📍 Daejeon Chungnam National University Hospital Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai) NCT06767605n/a1 site📍 Barcelona Asociación Española para el Estudio del Hígado A-LiNK: Improving Outcomes in Autoimmune Liver Disease NCT05750498n/a8 sites📍 Palo Alto📍 Indianapolis📍 St Louis Children's Hospital Medical Center, Cincinnati · Tests: No interventions
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy